Chronic kidney disease (CKD) is an increasing global health burden. Current treatments for
CKD include therapeutics to target factors that contribute to CKD progression, including …

Chronic kidney disease (CKD) is predominant in 10% of the world's adult population, and is
increasingly considered a silent epidemic. Gut microbiota plays an essential role in …

Treatment for non-alcoholic fatty liver disease (NAFLD) currently consists of lifestyle
modifications such as a low-fat diet, weight loss, and exercise. The gut microbiota forms part …

Chronic kidney disease (CKD) affects more than 10% population worldwide and becomes a
huge burden to the world. Recent studies have revealed multifold interactions between CKD …

Diabetes is the leading cause of kidney disease, and as the number of individuals with
diabetes increases there is a concomitant increase in the prevalence of diabetic kidney …

Gut microbiome contributes to host health by maintaining homeostasis, increasing digestive
efficiency, and facilitating the development of the immune system. Manipulating gut …

The acquisition of multicellularity has led to the higherorder organization of cells, tissues,
and organs over the course of evolution (1–4), which has necessitated the parallel …

Dysbiosis of gut microbiota plays a fundamental role in the pathogenesis and development
of chronic kidney disease (CKD) and its complications. Natural products from plants and …

The intestinal microbiome continues to shift and develop throughout youth and could play a
pivotal role in health and wellbeing throughout adulthood. Environmental and interpersonal …

Increasing application of antibiotics changes the gut microbiota composition, leading to
dysbiosis of the gut microbiota. Although growing evidence suggests the potential role of gut …